Pathways Study
Anthropometry (1)
- BL_BMI_EMR - Participant BMI at diagnosis (phv00396461.v1.p1)
Demographics (1)
- AGE_DX - Participant age at diagnosis (phv00396458.v1.p1)
Disease Events (8)
- AJCC_STG - AJCC Tumor Stage (phv00396462.v1.p1)
- Death - Confirmed death (phv00396470.v1.p1)
- DeathBC - Breast cancer contributes to death (phv00396472.v1.p1)
- ER - Estrogen receptor status (phv00396463.v1.p1)
- HER2 - Her2/Neu status (phv00396465.v1.p1)
- PR - Progesterone receptor status (phv00396464.v1.p1)
- Radiation - Radiation therapy status (phv00396469.v1.p1)
- Recur - Confirmed recurrence (phv00396473.v1.p1)
General Health (1)
- BREAST_SURGERY - Surgery type (phv00396466.v1.p1)
Medications (2)
- Chemo - Chemotherapy status (phv00396467.v1.p1)
- Hormone - Hormone therapy status (phv00396468.v1.p1)
Race and Ethnicity (2)
- Ethnicity - Participant ethnicity (phv00396459.v1.p1)
- Race - Participant race (phv00396460.v1.p1)
Other (19)
- ANALYTE_TYPE - Analyte type (phv00396480.v1.p1)
- BODY_SITE - Body site where sample was collected (phv00396478.v1.p1)
- CONSENT - Consent group (phv00396449.v1.p1)
- DeathYrs - Time from diagnosis to death (years) (phv00396471.v1.p1)
- DNA_Extraction - DNA extraction method (phv00396475.v1.p1)
- DNA_Source - DNA Source (phv00396476.v1.p1)
- HISTOLOGICAL_TYPE - Cell or tissue type or subtype of sample (phv00396479.v1.p1)
- IS_TUMOR - Tumor status (phv00396481.v1.p1)
- RecurYrs - Time from diagnosis to recurrence (years) (phv00396474.v1.p1)
- SAMPLE_ID - Sample ID (phv00396453.v1.p1)
- SAMPLE_ID - De-identified sample ID (phv00396477.v1.p1)
- SAMPLE_SOURCE - Sample source (phv00396455.v1.p1)
- SAMPLE_USE - Sample Use (phv00396454.v1.p1)
- SOURCE_SAMPLE_ID - Source sample ID (phv00396456.v1.p1)
- SOURCE_SUBJECT_ID - Source subject ID (phv00396451.v1.p1)
- SUBJECT_ID - De-identified subject ID (phv00396457.v1.p1)
- SUBJECT_ID - Subject ID (phv00396452.v1.p1)
- SUBJECT_ID - Subject ID (phv00396448.v1.p1)
- SUBJECT_SOURCE - Subject source (phv00396450.v1.p1)